| What it does | Point-of-care eye disease screening with AI and portable imaging hardware
| AI-powered decision support for skin cancer diagnosis
|
|---|
| Stage | Not given
| Not given
|
|---|
| Founded | Not given
| Not given
|
|---|
| Based in | US
| SE
|
|---|
| Pricing model | Not given
| Not given
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - FDA-cleared handheld imaging device with proprietary optical technology
- AI-based screening software for Diabetic Retinopathy, AMD, and Glaucoma
- User-friendly and easy to implement design
- Designed for point-of-care settings including primary care and retail health
| - 96% accuracy (AUC) in skin lesion assessment
- Analysis in 5 seconds
- 95% sensitivity and 85% specificity for melanoma
- 99.5% negative predictive value
- CE-marked medical device software
- Clinician retains final diagnostic decision
- Smartphone-based dermatoscopic image capture
- GDPR-compliant data processing
- EU-based secure cloud storage
- Continuous safety and performance monitoring
|
|---|
| What makes it different | - Brings specialized eye screening capabilities to accessible point-of-care settings
- Addresses barriers to specialist assessment including access, convenience, and cost
- Enables early diagnosis and intervention to prevent vision loss
| - 56% cost savings through faster diagnosis and reduced need for expert second opinions
- 79% fewer referrals through more accurate assessments and reduced false positives
- Created by and for doctors with close collaboration with dermatologists
- Clinically validated in prospective studies
- Immediate feedback during consultation without waiting for results
|
| Community votes | 0 | 0 |
| DR (Domain Rating by Ahrefs) | 19 ● no change since last check | 27 ▼ −1 (down) since last check |
| Trust Flow (Majestic) | 13 | 9 |
| Citation Flow (Majestic) | 12 | 27 |
| Referring domains (Majestic) | 67 | 67 |